MiR-214 Targets β-Catenin Pathway to Suppress Invasion, Stem-Like Traits and Recurrence of Human Hepatocellular Carcinoma

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Xia, Hongping ^a   Ooi, London Lucien P J ^b   Hui, Kam M ^a,c,d,e  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; EPITHELIAL CELL ADHESION MOLECULE; MICRORNA 214; TRANSCRIPTION FACTOR EZH2; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOGENICITY; CARCINOMA CELL STEM LIKE TRAIT; CLINICAL ARTICLE; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; GENETIC REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER METASTASIS; MALE; MOUSE; NONHUMAN; ONCOLOGICAL PARAMETERS; PROTEIN INDUCTION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; TISSUE SECTION; UPREGULATION;

ANIMALS; BETA CATENIN; CADHERINS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; POLYCOMB REPRESSIVE COMPLEX 2; PROTEIN BINDING; SIGNAL TRANSDUCTION; SURVIVAL RATE; TUMOR CELLS, CULTURED;

EID: 84866040307     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044206     Document Type: Article

References (48)

1. Sanyal AJ, Yoon SK, Lencioni R, (2010) The Etiology of Hepatocellular Carcinoma and Consequences for Treatment. The Oncologist 15: 14-22.
2. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
3. Pei Y, Zhang T, Renault V, Zhang X, (2009) An overview of hepatocellular carcinoma study by omics-based methods. Acta Biochim Biophys Sin 41: 1-15.
4. Wang SM, Ooi LLPJ, Hui KM, (2011) Upregulation of Rac GTPase-Activating Protein 1 Is Significantly Associated with the Early Recurrence of Human Hepatocellular Carcinoma. Clin Cancer Res 17: 6040-6051.
5. Villanueva A, Llovet JM, (2011) Targeted Therapies for Hepatocellular Carcinoma. Gastroenterology 140: 1410-1426.
6. Esquela-Kerscher A, Slack FJ, (2006) Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
7. Babashah S, Soleimani M, (2011) The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis. Eur J Cancer 47: 1127-1137.
8. Law PTY, Wong N, (2011) Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma. J Gastroenterol Hepatol 26: 437-449.
9. Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, et al. (2007) Cyclin G1 Is a Target of miR-122a, a MicroRNA Frequently Down-regulated in Human Hepatocellular Carcinoma. Cancer Res 67: 6092-6099.
10. Wong CCL, Wong CM, Tung EKK, Au SLK, Lee JMF, et al. (2011) The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2. Gastroenterology 140: 322-331.
11. Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, et al. (2008) Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival. Clin Cancer Res 14: 419-427.
12. Li W, Xie L, He X, Li J, Tu K, et al. (2008) Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma. Int J Cancer 123: 1616-1622.
13. Wang Y, Lee ATC, Ma JZI, Wang J, Ren J, et al. (2008) Profiling MicroRNA Expression in Hepatocellular Carcinoma Reveals MicroRNA-224 Up-regulation and Apoptosis Inhibitor-5 as a MicroRNA-224-specific Target. J Biol Chem 283: 13205-13215.
14. Xia H, Cheung WKC, Sze J, Lu G, Jiang S, et al. (2010) miR-200a regulates epithelial-mesenchymal to stem-like transition via ZEB2 and beta-catenin signaling. J Biol Chem 285: 36995-37004.
15. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-[Delta][Delta] CT method. Methods 25: 402-408.
16. Lu J, He M-L, Wang L, Chen Y, Liu X, et al. (2011) MiR-26a Inhibits Cell Growth and Tumorigenesis of Nasopharyngeal Carcinoma through Repression of EZH2. Cancer Res 71: 225-233.
17. Fuchs BC, Fujii T, Dorfman JD, Goodwin JM, Zhu AX, et al. (2008) Epithelial-to-Mesenchymal Transition and Integrin-Linked Kinase Mediate Sensitivity to Epidermal Growth Factor Receptor Inhibition in Human Hepatoma Cells. Cancer Res 68: 2391-2399.
18. Juan AH, Kumar RM, Marx JG, Young RA, Sartorelli V, (2009) Mir-214-Dependent Regulation of the Polycomb Protein Ezh2 in Skeletal Muscle and Embryonic Stem Cells. Mol Cell 36: 61-74.
19. Xiao F, Zuo Z, Cai G, Kang S, Gao X, et al. (2009) miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res 37: D105-D110.
20. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, et al. (1997) Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC. Science 275: 1787-1790.
21. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, et al. (2008) Loss of E-Cadherin Promotes Metastasis via Multiple Downstream Transcriptional Pathways. Cancer Res 68: 3645-3654.
22. Miranda KC, Khromykh T, Christy P, Le TL, Gottardi CJ, et al. (2001) A Dileucine Motif Targets E-cadherin to the Basolateral Cell Surface in Madin-Darby Canine Kidney and LLC-PK1 Epithelial Cells. J Biol Chem 276: 22565-22572.
23. Cao Q, Yu J, Dhanasekaran SM, Kim JH, Mani RS, et al. (2008) Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene 27: 7274-7284.
24. Cheng ASL, Lau SS, Chen Y, Kondo Y, Li MS, et al. (2011) EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin-Dependent Hepatocarcinogenesis. Cancer Res 71: 4028-4039.
25. Yamashita T, Ji J, Budhu A, Forgues M, Yang W, et al. (2009) EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 136 1012-1024: e1014.
26. Ji J, Yamashita T, Budhu A, Forgues M, Jia H-L, et al. (2009) Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology 50: 472-480.
27. Oishi N, Wang XW, (2011) Novel therapeutic strategies for targeting liver cancer stem cells. Int J Biol Sci 7: 517.
28. Duan Q, Wang X, Gong W, Ni L, Chen C, et al. (2012) ER Stress Negatively Modulates the Expression of the miR-199a/214 Cluster to Regulates Tumor Survival and Progression in Human Hepatocellular Cancer. PLoS ONE 7: e31518.
29. Yang H, Kong W, He L, Zhao J-J, O'Donnell JD, et al. (2008) MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN. Cancer Res 68: 425-433.
30. Qiang R, Wang F, Shi L-Y, Liu M, Chen S, et al. (2011) Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells. Int J Biochem Cell Biol 43: 632-641.
31. Yang Z, Chen S, Luan X, Li Y, Liu M, et al. (2009) MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells. IUBMB Life 61: 1075-1082.
32. Derfoul A, Juan A, Difilippantonio MJ, Palanisamy N, Ried T, et al. (2011) Decreased MicroRNA-214 Levels In Breast Cancer Cells Coincides with Increased Cell Proliferation, Invasion, and Accumulation of the Polycomb Ezh2 Methyltransferase. Carcinogenesis 32: 1607-1614.
33. Bar-Eli M, (2011) Searching for the/'melano-miRs/': miR-214 drives melanoma metastasis. EMBO J 30: 1880-1881.
34. Penna E, Orso F, Cimino D, Tenaglia E, Lembo A, et al. (2011) microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C. EMBO J 30: 1990-2007.
35. Baek D, Villén J, Shin C, Camargo FD, Gygi SP, et al. (2008) The impact of microRNAs on protein output. Nature 455: 64-71.
36. Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, et al. (2005) Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37: 766-770.
37. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, et al. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773.
38. Selbach M, Schwanhäusser B, Thierfelder N, Fang Z, Khanin R, et al. (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455: 58-63.
39. Chase A, Cross NCP, (2011) Aberrations of EZH2 in Cancer. Clin Cancer Res 17: 2613-2618.
40. Cai M-Y, Tong Z-T, Zheng F, Liao Y-J, Wang Y, et al. (2011) EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies. Gut 60: 967-976.
41. Zeng G, Apte U, Cieply B, Singh S, Monga SPS, (2007) siRNA-mediated Â-catenin knockdown in human hepatoma cells results in decreased growth and survival. Neoplasia (New York, NY) 9: 951.
42. Dahmani R, Just P-A, Perret C, (2011) The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma. Clin Res Hepatol Gastroenterol 35: 709-713.
43. Watabe M, Nagafuchi A, Tsukita S, Takeichi M, (1994) Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line. J Cell Biol 127: 247-256.
44. Adams CL, Nelson WJ, Smith SJ (1996) Quantitative analysis of cadherin-catenin-actin reorganization during development of cell-cell adhesion. J Cell Biol: 1899-1911.
45. Yap AS, Brieher WM, Gumbiner BM, (1997) Molecular and functional analysis of cadherin-based adherens junctions. Annu Rev Cell Dev Biol 13: 119-146.
46. Jordan CT, Guzman ML, Noble M, (2006) Cancer Stem Cells. N Engl J Med 355: 1253-1261.
47. Visvader JE, Lindeman GJ, (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8: 755-768.
48. Kanwar SS, Yu Y, Nautiyal J, Patel BB, Majumdar APN, (2010) The Wnt/β-catenin pathway regulates growth and maintenance of colonospheres. Mol Cancer 9: 212.